Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.64 +0.06 (+0.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Fennec Pharmaceuticals (FENC) Gains from Sales and Divestitures (2009 - 2014)

Updated

Analysis

Fennec Pharmaceuticals (FENC) Gains from Sales and Divestitures (2009 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Fennec Pharmaceuticals 370.66 Mn 230.50 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 386,000.00
Jun 30, 2014 386,000.00
Mar 31, 2014 386,000.00
Dec 31, 2013 386,000.00
Dec 31, 2010 -772,000.00
Sep 30, 2010 386,000.00
Jun 30, 2010 386,000.00
Mar 31, 2010 386,000.00
Sep 30, 2009 57,000.00
Jun 30, 2009 -11,000.00
Mar 31, 2009 340,000.00
API Access

Fennec Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=FENC&period=max&api_key=YOUR_API_KEY